Nichi-Iko to acquire Sagent Pharmaceuticals for $736 million
Nichi-Iko Pharmaceutical Co. will acquire Sagent Pharmaceuticals for $736 million, subject to customary regulatory approvals. The acquisition brings together two leading companies... Read More